Healix

Meet the Healix Team at IDWeek 2024

Los Angeles, CA

We’re excited to announce that Healix will be exhibiting at IDWeek 2024 in Los Angeles! Each year, IDWeek is the joint meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. Healix is proud to once again participate in this premier ID conference that brings together clinicians, researchers, and healthcare professionals to share the latest advancements in patient care and disease prevention.

At the meeting, be sure to visit our team at booth #241 in the Exhibit Hall to learn about how our infusion management services and clinical research support the ID community. To learn more ahead of the show or to schedule a private meeting, please don’t hesitate to contact us.  Learn more about our comprehensive service offerings.

Not yet registered to attend IDWeek? It’s not too late — sign up today at https://idweek.org/.  We hope to connect with you in sunny LA!

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound